News | April 03, 2026
ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
FDA authorization was based on two years of clinical study data demonstrating that Essilor Stellest lenses significantly slowed myopia progression compared to single-vision control lenses
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The average time of dilation lasts three to eight hours
Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
Take proper precautions and seek timely treatment!
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Subscribe To Our Newsletter & Stay Updated
